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Abstract
Background:  Most epidemiologic studies concerned with Major Depressive Disorder have
employed cross-sectional study designs. Assessment of lifetime prevalence in such studies depends
on recall of past depressive episodes. Such studies may underestimate lifetime prevalence because
of incomplete recall of past episodes (recall bias). An opportunity to evaluate this issue arises with
a prospective Canadian study called the National Population Health Survey (NPHS).
Methods: The NPHS is a longitudinal study that has followed a community sample representative
of household residents since 1994. Follow-up interviews have been completed every two years and
have incorporated the Composite International Diagnostic Interview short form for major
depression. Data are currently available for seven such interview cycles spanning the time frame
1994 to 2006. In this study, cumulative prevalence was calculated by determining the proportion
of respondents who had one or more major depressive episodes during this follow-up interval.
Results: The annual prevalence of MDD ranged between 4% and 5% of the population during each
assessment, consistent with existing literature. However, 19.7% of the population had at least one
major depressive episode during follow-up. This included 24.2% of women and 14.2% of men.
These estimates are nearly twice as high as the lifetime prevalence of major depressive episodes
reported by cross-sectional studies during same time interval.
Conclusion: In this study, prospectively observed cumulative prevalence over a relatively brief
interval of time exceeded lifetime prevalence estimates by a considerable extent. This supports the
idea that lifetime prevalence estimates are vulnerable to recall bias and that existing estimates are
too low for this reason.
Background
Lifetime prevalence is one of the most frequently reported
parameters in psychiatric epidemiology. Lifetime preva-
lence represents the proportion of the population who
have experienced a disorder at some time in their life up
to the time of interview. In the case of Major Depressive
Disorder, this is the proportion of the population who
have experienced a major depressive episode (MDE) but
not a manic, hypomanic or mixed episode and who do
not have a concurrent psychotic disorder. In Canada, the
lifetime prevalence of MDE is 12.2% [1] as determined by
a national survey called the Canadian Community Health
Survey, Mental Health and Wellbeing (CCHS 1.2) con-
ducted in 2002. Similar values have been reported by a
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methodologically comparable European study [2]. Higher
values have been reported in the US: 16–18% [3,4]. The
Canadian study reported a prevalence of past year epi-
sodes of 4.8% [1].
Concerns have been expressed about the validity of life-
time prevalence estimates. Andrews et al. followed a
cohort that had been admitted to hospital with depressive
disorders and found that only about half of these were
able to recount their symptoms in a way that was detected
by the Composite International Diagnostic Interview
(CIDI) 25 years later [5]. The CIDI is the measurement
instrument used in each of the lifetime prevalence studies
listed above. A tendency to forget about past symptoms or
episodes could also explain the otherwise puzzling failure
of lifetime prevalence estimates to increase with age [6].
Kruijshaar et al. [7] combined data from the Netherlands
Mental Health Survey and Incidence Study (NEMESIS)
with the Australian National Study of Mental Health and
Wellbeing using a micro-simulation model to explore the
role of recall bias. Their results suggested that lifetime
prevalence estimates may substantially underestimate the
true population values. Discussing some of these observa-
tions in a 2005 editorial, Andrews et al. speculated that
more than half of the population may experience an epi-
sode of MD at some time during their lives [8], far in
excess of lifetime prevalence estimates from published
cross-sectional studies.
A longitudinal study conducted in Canada provides an
opportunity to explore some of these issues. The National
Population Health Survey (NPHS) is a general population
survey that has included a brief instrument designed to
detect past year major depressive episodes, the CIDI short
form for major depression (CIDI-SFMD) [9]. In seven
interview cycles starting in 1994 and continuing to 2006
the CIDI-SFMD would detect episodes occurring in seven
one year intervals. In the absence of recall bias it is reason-
able to hypothesize that the proportion of the population
reporting an episode during the NPHS should be consid-
erably more than the annual prevalence of MDE, but con-
siderably less than the lifetime prevalence. Canadian
lifetime and annual prevalence estimates, see above, also
derive from a cross-sectional survey called the Canadian
Community Health Survey, Mental Health and Wellbeing
(CCHS 1.2). This study used a similar sampling frame and
collected data in 2002, however, the CCHS 1.2 used an
adaptation of the World Mental Health version of the
CIDI [10].
Methods
The NPHS is a longitudinal study based on a nationally
representative community sample assembled by Statistics
Canada (Canada's national statistical agency) in 1994.
The target population for the NPHS consisted of house-
hold residents and did not include homeless persons or
residents of institutions. Members of the Canadian Armed
Forces, those living on First Nation reserves, and residents
of certain remote locations were excluded from the sam-
pling frame. Interviews were conducted in person in 1994
at the beginning of the study, but most of the follow-up
interviews have been conducted by telephone. NPHS
respondents are interviewed every two years. All of the
interviews were carried out by trained and experienced
interviewers. Detailed information about the NPHS meth-
ods may be found on the Statistics Canada Web page
http://www.StatCan.gc.ca. The NPHS longitudinal cohort
included 17,276 participants, but the current analysis was
restricted initially to n = 15,254 respondents who were
over the age of 12 at the time of the initial 1994 baseline
interview. The sample was further restricted to those with
complete data collection up to the 2006 interview. Mem-
bers of the cohort that died, were institutionalized or were
lost to follow-up prior to the 2006 interview were
excluded. This resulted in the final inclusion of n = 7,457
respondents in the analysis presented here.
The CIDI-SFMD uses a point-based scoring algorithm that
incorporates the number of symptom-based criteria ful-
filled and the necessity for at least one of two key symp-
toms (depressed mood and loss of interest or pleasure) in
keeping with the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV) [11]. This cut-point also max-
imized performance of the CIDI-SFMD in a DSM-IIIR-
based receiver operator curve analysis carried out during
the instrument's development [9]. The CIDI-SFMD does
not apply all of the exclusion criteria that are present in
DSM-IV. The DSM-IV diagnostic criteria for major depres-
sive episodes have exclusion criteria for episodes that are
judged due to the death of a loved one, the effects of a
drug or medication or a general medical condition. As the
CIDI-SFMD does not apply these exclusions, it may be
vulnerable to false positive ratings. Consistent with this
idea, experience with the instrument suggests that it may
slightly overestimate prevalence [12]. However, any such
effects must be modest in magnitude, as the CIDI-SFMD
has produced credible estimates during applications in
Canada [13,14], the US [15,16] and elsewhere [17]. In the
NPHS and related surveys the CIDI-SMFD has consist-
ently replicated the expected pattern and strength of asso-
ciation with demographic and clinical variables [14,18-
20]. Furthermore, incidence estimates from the CIDI-
SFMD [19,20] are consistent with those of a systematic
review of high quality studies by Waraich et al. [21].
All estimates deriving from the NPHS were weighted using
sampling weights that account for design features of the
study. Because of the complexity of the NPHS sampling
strategy, a variance calculation method based on a boot-
strap procedure employing 500 replicate samplingBMC Psychiatry 2009, 9:19 http://www.biomedcentral.com/1471-244X/9/19
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weights was employed. The study received ethical
approval from the University of Calgary Conjoint Health
Research Ethics Board.
Results
The pattern of accumulation of MDE is depicted in figure
1. Prevalence at the 1994 interview was 5.3% (95% CI 4.7
– 5.9), and was higher in women (7.0%, 95% CI 6.0 –
8.0) than in men (3.2%, 95% CI 2.4 – 4.0). This 1994
annual prevalence estimate was the highest observed in
the seven interviews, with the remainder varying between
a low of 4.4% (95% CI 3.8% – 5.0%) in 1998 and a high
of 5.0% (95% CI 4.3% – 5.6%) in 2004. Nevertheless, as
depicted in figure 1, cumulative prevalence exceeded that
of reported Canadian lifetime prevalence. By 2006 the
cumulative prevalence was 14.2% in men (95% CI 12.3 –
16.0) and 24.2% in women (95% CI 22.5 – 26.0). In both
sexes combined the prevalence was 19.7% (95% CI 18.4
– 21.0). Although the annual prevalence estimates from
the NPHS were consistent with estimated annual preva-
lence in the CCHS 1.2 (4.8%), the cumulative prevalence
was nearly twice that of retrospectively assessed lifetime
prevalence.
Discussion
The hypothesis proposed earlier in the analysis: that the
cumulative prevalence of MDE over 13 years of follow-up
would exceed the annual prevalence of MDE and be lower
than lifetime prevalence was not confirmed by the analy-
sis. The accumulation of cases over this relatively brief
interval of time substantially exceeded accepted values for
lifetime prevalence.
Although the duration of follow-up was 13 years in the
sense that data from 1994 to 2006 were used, the CIDI-
SFMD items actually only fully covered seven of these
years. Many episodes would be expected to begin in one
year and end in another, such that the duration of follow-
up is best considered greater than seven years but less than
thirteen. In any case, the cumulative prevalence over this
relatively brief interval far exceeds expectation based on
retrospectively assessed lifetime prevalence. Canadian
lifetime prevalence from the CCHS 1.2 was 12.2% [1]:
only about 60% of the observed cumulative prevalence in
the NPHS. The CCHS 1.2 estimate was highly precise
(95% CI 11.7 to 12.7), so sampling variability cannot
account for the discrepancy reported here. The CCHS 1.2
was conducted in 2002, during same interval covered by
the NPHS. Hence, a secular trend in prevalence cannot
explain the results either. The most probable explanation
is recall bias. However, the analysis presented here cannot
directly confirm this possibility. An alternative explana-
tion is that the CIDI-SFMD may generate false positive rat-
ings and thereby overestimate cumulative prevalence.
This explanation seems unlikely, however, when one con-
siders that annual prevalence estimates from the NPHS
cohort were in close alignment with estimates from other
studies, including the CCHS 1.2. A small false positive rate
could over time translate into a greater accumulation of
episodes during multiple interviews, but an effect of this
type seems unlikely to be able to account for the consider-
able extent to which observed cumulative prevalence
exceeded accepted values for lifetime prevalence in this
study.
Even though the CIDI-SFMD did not appear to over-iden-
tify MDE in the NPHS, it is possible that the annual prev-
alence identified by the CIDI-SFMD represents a balance
between poor specificity and poor sensitivity. In other
words, the increased prevalence expected if the instru-
ment produces false positive results could be offset by
reduced sensitivity to true MDE, resulting in false nega-
tives. The net result may be that the CIDI-SFMD produces
reasonable annual prevalence estimates, but that these
estimates include some cases of other conditions such as
bereavement or adjustment disorder that, in turn, may
accumulate over time in the cohort.
Conclusion
For the reasons stated above, this study cannot definitively
confirm that existing lifetime prevalence estimates are too
low. However, it does strongly reinforce a growing litera-
ture suggesting that this is the case [5-7]. Accumulating
evidence draws the validity of lifetime diagnostic inter-
views, and their role in psychiatric epidemiologic
research, into question.
What is the best solution to these problems? One solution
is to determine period prevalence through longitudinal
follow-up rather than cross-sectionally, as was done in the
Cumulative prevalence of MDE in the NPHS 1994 – 2006 Figure 1
Cumulative prevalence of MDE in the NPHS 1994 – 
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NPHS. Unfortunately, this approach can be prohibitively
expensive. Another solution is to evaluate current preva-
lence such that symptoms can be assessed without relying
on recall. However, this may reduce the power and achiev-
able precision of studies because a smaller number of
respondents would be identified as having an episode.
Another option, albeit not one that can address the issue
of precision, involves modification of the current
approach taken by structured interviews. Instruments
such as the CIDI begin with screening questions that refer
to lifetime episodes and then explore these episodes in
detail, returning to the more recent past through the inclu-
sion of a small number of items asking about the timing
of similar recent episodes. This emphasis should perhaps
be reversed so that the instruments can obtain a valid and
detailed assessment of current mental health status and
then assess past history using a smaller number of items.
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